Hermia | Dosimetry

Advancing personalized dosimetry and theranostics

The future of personalized therapy for treating complex liver, prostate, and neuroendocrine cancers is here. Hermes Medical Solutions is committed to the advancement and future of personalized care. Optimizing patient outcomes and delivering cost-effective, cutting-edge treatment relies on providing individualized dosimetry for each patient.

Experience Hermia, our all-in-one vendor-neutral solution for your dosimetry work. Our complete suite of advanced tools, including Hermia Voxel Dosimetry, Hermia Organ Dosimetry and Hermia SIRT treatment planning and verification, enables your department to continue advancing cancer treatment. 

Together we can develop personalized, precise treatment and therapy options and continue to push the forefront of medicine.

Several approaches to dosimetry

We provide you with three possible approaches to dosimetry where integrated tools and workflows save time and decrease chance of error transferring measurements between tools:

1. Hermia Voxel Dosimetry 

For accurate and personalized dose calculations

2. Hermia Organ Dosimetry with Olinda/EXM

Optimal for clinical use integrating Olinda into a seamless workflow.

3. Hermia SIRT

A cutting-edge approach for treatment of liver tumors either from primary or metastatic liver cancer, helping to plan and verify accurate doses.

We also offer Olinda/EXM as a stand-alone application. Olinda in this format is CE-marked and FDA-cleared. However, it requires manual data-entry and up-front calculations and Hermes Medical Solutions doesn't provide service nor a set-up for it. For clinical dosimetry work we recommend any of our three other solutions for which we offer support from our experts with clinical background in nuclear medicine.